Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Non-cash Items (2024 - 2025)

Bioregenx's Non-cash Items history spans 2 years, with the latest figure at $37.4 million for Q4 2025.

  • Quarterly results put Non-cash Items at $37.4 million for Q4 2025, up 3241.73% from a year ago — trailing twelve months through Dec 2025 was $37.4 million (up 3241.73% YoY), and the annual figure for FY2025 was $37.4 million, up 3241.73%.
  • Non-cash Items for Q4 2025 was $37.4 million at Bioregenx, down from $41.6 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $41.6 million in Q3 2025 to a low of $1.1 million in Q1 2024.